170 related articles for article (PubMed ID: 12620298)
1. Waldenstrom's macroglobulinemia: is there a place and time for a cease-fire?
Zinzani PL; Tani M; Alinari L; Stefoni V; Baccarani M
Leuk Res; 2003 May; 27(5):465-6. PubMed ID: 12620298
[No Abstract] [Full Text] [Related]
2. Rituximab-based treatments in Waldenström's macroglobulinemia.
Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
[TBL] [Abstract][Full Text] [Related]
3. Real-world treatment patterns and outcomes in a national study of veterans with Waldenström macroglobulinemia, 2006-2019.
Chien HC; Morreall D; Patil V; Rasmussen KM; Yong CM; Li CY; Passey DG; Burningham Z; Sauer BC; Halwani AS
Am J Hematol; 2021 Jun; 96(6):E184-E187. PubMed ID: 33606890
[No Abstract] [Full Text] [Related]
4. Alkylating Agents in the Treatment of Waldenström Macroglobulinemia.
Buske C
Hematol Oncol Clin North Am; 2018 Oct; 32(5):821-827. PubMed ID: 30190020
[TBL] [Abstract][Full Text] [Related]
5. [Waldenstrom macroglobulinemia].
Kolyvanos Naumann U; Käser L; Vetter W
Praxis (Bern 1994); 2004 Mar; 93(14):547-52, 577. PubMed ID: 15125068
[No Abstract] [Full Text] [Related]
6. Waldenström's macroglobulinemia.
Desikan KR; Dhodapkar MV; Barlogie B
Curr Treat Options Oncol; 2000 Jun; 1(2):97-103. PubMed ID: 12057047
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy and combination of cladribine, cyclophosphamide, and prednisone as treatment of Bing-Neel syndrome: Case report and review of the literature.
Delgado J; Canales MA; Garcia B; Alvarez-Ferreira J; Garcia-Grande A; Hernandez-Navarro F
Am J Hematol; 2002 Feb; 69(2):127-31. PubMed ID: 11835349
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Waldenström´s macroglobulinaemia in the year 2014].
Adam Z; Krejčí M; Pour L; Ševčíková E
Vnitr Lek; 2014 Feb; 60(2):139-57. PubMed ID: 24754419
[TBL] [Abstract][Full Text] [Related]
9. Waldenström's macroglobulinemia: a review of therapy.
Gertz MA
Leuk Lymphoma; 2002 Aug; 43(8):1517-26. PubMed ID: 12400593
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
[TBL] [Abstract][Full Text] [Related]
11. What's new in Waldenström macroglobulinemia.
Gertz MA
Leuk Lymphoma; 2010 Oct; 51(10):1765-6. PubMed ID: 20846101
[No Abstract] [Full Text] [Related]
12. Unresolved issues in the comparison of therapies and determination of responses in Waldenström macroglobulinemia.
Peinert S; Seymour JF
Leuk Lymphoma; 2010 Oct; 51(10):1767-70. PubMed ID: 20919859
[No Abstract] [Full Text] [Related]
13. [Polychimiotherapy and Waldenström's macroglobulinemia (author's transl)].
Barrier J; Grolleau JY; Renault JJ; Ozanne P; Bouret O
Sem Hop; 1979 Dec 8-15; 55(41-42):1925-6. PubMed ID: 231315
[TBL] [Abstract][Full Text] [Related]
14. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia.
Treon SP; Gertz MA; Dimopoulos M; Anagnostopoulos A; Blade J; Branagan AR; Garcia-Sanz R; Johnson S; Kimby E; Leblond V; Fermand JP; Maloney DG; Merlini G; Morel P; Morra E; Nichols G; Ocio EM; Owen R; Stone MJ
Blood; 2006 May; 107(9):3442-6. PubMed ID: 16410453
[TBL] [Abstract][Full Text] [Related]
15. Clinical investigations in aggressive non-Hodgkin lymphoma.
Jonathan F
Clin Adv Hematol Oncol; 2008 Sep; 6(9):7-8. PubMed ID: 18998259
[No Abstract] [Full Text] [Related]
16. [Changes in the prognosis and treatment of Waldenström macroglobulinemia. Literature overview and own experience].
Adam Z; Pour L; Krejčí M; Ševčíková S; Pourová E; Ševčíková E; Král Z; Mayer J
Vnitr Lek; 2016 Jan; 62(1):25-39. PubMed ID: 26967234
[TBL] [Abstract][Full Text] [Related]
17. Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia.
Ioakimidis L; Patterson CJ; Hunter ZR; Soumerai JD; Manning RJ; Turnbull B; Sheehy P; Treon SP
Clin Lymphoma Myeloma; 2009 Mar; 9(1):62-6. PubMed ID: 19362976
[TBL] [Abstract][Full Text] [Related]
18. Guidelines on the management of Waldenström macroglobulinaemia.
Johnson SA; Birchall J; Luckie C; Oscier DG; Owen RG;
Br J Haematol; 2006 Mar; 132(6):683-97. PubMed ID: 16487169
[No Abstract] [Full Text] [Related]
19. Splenic re-irradiation for waldenstrőm's macroglobulinemia.
Wei Z; Yanxia Y; Ying X; Han W; Yuhua J
Radiat Oncol; 2012 Apr; 7():58. PubMed ID: 22497910
[TBL] [Abstract][Full Text] [Related]
20. [Bing-Neel syndrome revealing Waldenström's macroglobulinemia].
Drouet T; Behin A; Psimaras D; Choquet S; Guillevin R; Hoang Xuan K
Rev Neurol (Paris); 2010 Jan; 166(1):66-75. PubMed ID: 19403149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]